• About us
• Contact

Advertisement

Organisation › Details

Sophia Genetics (Group)

Leader in Data-Driven Medicine, SOPHiA GENETICS is a health tech company which has developed SOPHiA AI, the advanced technology helping healthcare professionals make sense of the large amount of clinical data. SOPHiA GENETICS is democratizing Data-Driven Medicine by enabling the rapid adoption of genomic and radiomic analysis worldwide, turning data into actionable clinical insights, and sharing knowledge through its community. The company's achievements and innovative approach are recognized by MIT Technology Review's "50 Smartest Companies 2017" and Fast Company's "Most Innovative Companies 2018." *

 

	Start	2011-03-01 established
	Industry	Sophia DDM (Data Driven Medicine)
	Industry 2	dropGen™ bioinformatics platform
	Person	Camblong, Jurgi (Sophia Genetics 201407 CEO + Co-Founder)
	Person 2	Muken, Ross (Sophia Genetics 202102– CFO before Click Therapeutics 201907– CFO before ISI Group + Deutsche Bank)
	Region	Lausanne VD
	Country	Switzerland
	Street	172 Rue du Centre
	City	1025 Saint Sulpice
	Tel	+41-21-694-1060
		Address record changed: 2024-01-05
Basic data	Employees	D: 101 to 500 (2022-12-31)
	Currency	USD
	Annual sales	47,560,000 (revenue, annual, consolidated (2022) 2022-12-31)
	Profit	-87,449,000 (2022-12-31)
	Cash	161,305,000 (2022-12-31)
		* Document for »About Section«: Sophia Genetics S.A.. (1/4/19). "Press Release: Sophia Genetics Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine". San Francisco, CA.
		Record changed: 2023-08-29

Advertisement

More documents for Sophia Genetics (Group)

• [1] Sophia Genetics S.A.. (8/22/23). "Press Release: Sophia Genetics Expands Relationship with Gustave Roussy". Boston, MA & Rolle....
• [2] Sophia Genetics S.A.. (7/19/23). "Press Release: Sophia Genetics Supports Sofiva Genomics to Launch New HRD Test". Boston, MA & Rolle....
• [3] Sophia Genetics S.A.. (5/31/23). "Press Release: Sophia Genetics Announces Nomination of Lila Tretikov to Board of Directors". Boston, MA & Lausanne....
• [4] Isopmorphic Labs Ltd.. (5/12/22). "Press Release: Isomorphic Labs Announces First Phase of Management Team". London....
• [5] Sophia Genetics S.A.. (7/22/21). "Press Release: Sophia Genetics Announces Pricing of Initial Public Offering". Boston, MA & Lausanne....
• [6] Endeavour Vision. (4/22/21). "Press Release: Endeavour Vision Closes Endeavour Medtech Growth II LP at USD 375m to Invest in Transformative Healthcare Technologies". St. Peter Port, Geneva & Minneapolis, MN....
• [7] Sophia Genetics S.A.. (2/11/21). "Press Release: Sophia Genetics Appoints Ross Muken as Chief Financial Officer". Boston, MA & Lausanne....
• [8] Sophia Genetics S.A.. (1/19/21). "Press Release: Sophia Genetics Appoints Influential Regulatory Figure Kathy L. Hibbs to Board of Directors". Boston, MA & Lausanne....
• [9] Sophia Genetics S.A.. (1/19/21). "Press Release: Sophia Genetics and the Spanish Lung Cancer Group Team Up to Explore the Predictive Potential of Multimodal Health Data in Resectable Stage IIIA Non-Small Cell Lung Cancer". Boston, MA & Lausanne....
• [10] Sophia Genetics S.A.. (11/17/20). "Press Release: Bram Goorden Joins Sophia Genetics as Chief Commercial Officer and Head of North America". Boston, MA & Lausanne....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.